HP
DXCM icon

HealthInvest Partners’s DexCom DXCM Stock Holding History

HealthInvest Partners’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.84M Sell
71,846
-512,486
-88% -$34.1M 1.3% 32
2026
Q1 		$2.64M Buy
584,332
+544,610
+1,371% +$37.9M 0.85% 36
2025
Q4 		$2.64M Sell
39,722
-11,150
-22% -$721K 0.84% 35
2025
Q3 		$3.42M Hold
50,872
– – 1.35% 26
2025
Q2 		$4.44M Buy
50,872
+5,031
+11% +$394K 1.9% 21
2025
Q1 		$3.13M Sell
45,841
-14,216
-24% -$1.16M 1.38% 22
2024
Q4 		$4.68M Buy
60,057
+6,300
+12% +$466K 2.22% 16
2024
Q3 		$3.6M Buy
53,757
+19,274
+56% +$1.58M 1.69% 18
2024
Q2 		$3.91M Buy
34,483
+8,200
+31% +$1.04M 2.38% 12
2024
Q1 		$3.65M Buy
26,283
+8,226
+46% +$1.03M 2.22% 18
2023
Q4 		$2.24M Buy
+18,057
New +$1.84M 1.75% 21
2022
Q4 		$33.9K Buy
+299
New +$32.8K 0.07% 24

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

HealthInvest Partners's DXCM Position: Q2 2026 in Review

HealthInvest Partners reduced its DexCom (DXCM) stake by 88% in Q2 2026, selling an estimated $34.1M and leaving 71,846 shares worth $4.84M. The position accounts for 1.3% of the portfolio, ranked #32.

HealthInvest Partners first reported a position in DXCM in Q4 2022 and has held it in 12 quarters since. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • HealthInvest Partners held 71,846 shares of DexCom worth $4.84M as of Q2 2026.
  • HealthInvest Partners sold 512,486 DexCom shares in Q2 2026, an estimated $34.1M.
  • DexCom made up 1.3% of HealthInvest Partners's portfolio in Q2 2026, its #32 holding.
  • HealthInvest Partners first reported a position in DexCom in Q4 2022 and has held it in 12 quarters since.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on HealthInvest Partners's 13F filing for Q2 2026, filed 24 Jul 2026.